Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Figeac, N
19  Ergebnisse:
Personensuche X
?
1

P65 Designing 3D scaffolds that can support myogenic progre..:

Figeac, N. ; Zammit, P.S.
Neuromuscular Disorders.  24 (2014)  - p. S24 , 2014
Link: https://doi.org/10.1016/..
 
?
2

P21 ErbB3 binding protein-1 (Ebp1) contributes to the contr..:

Figeac, N. ; Zammit, P.S.
Neuromuscular Disorders.  21 (2011)  - p. S12 , 2011
Link: https://doi.org/10.1016/..
 
?
3

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myog..:

Figeac, N ; Mohamed, AD ; Sun, C...
Journal of cell science, 2019, 132 (13).  , 2020
Link: https://repository.icr.a..
 
?
4

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myog..:

Figeac, N ; Mohamed, A.D ; Sun, C...
info:eu-repo/semantics/altIdentifier/doi/10.1242/jcs.225946.  , 2019
Link: https://serval.unil.ch/n..
 
?
5

Impairments in contractility and cytoskeletal organisation ..:

Ross J. A ; Levy Y ; Ripolone M...
info:eu-repo/semantics/altIdentifier/pmid/31218456.  , 2019
Link: http://hdl.handle.net/11..
 
?
6

Impairments in contractility and cytoskeletal organisation ..:

Ross, JA ; Levy, Y ; Ripolone, M...
https://discovery.ucl.ac.uk/id/eprint/10089880/1/Impairments%20in%20contractility%20and%20cytoskeletal%20organisation%20cause%20nuclear%20defects%20in%20nemaline%20myopathy.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
7

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myog..:

Figeac, N ; Mohamed, A.D ; Sun, C...
info:eu-repo/semantics/altIdentifier/doi/10.1242/jcs.225946.  , 2019
Link: https://push-zb.helmholt..
 
?
8

Dynamic transcriptomic analysis reveals suppression of PGC1..:

Banerji, CRS ; Panamarova, M ; Pruller, J...
https://discovery.ucl.ac.uk/id/eprint/10065163/1/ddy405.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
9

282 Familial myelodysplastic syndrome/acute myeloid leukemi..:

Bastard, A. Stamatoullas ; Loschi, M. ; Figeac, M....
Leukemia Research.  35 (2011)  - p. S111 , 2011
Link: https://doi.org/10.1016/..
 
?
10

The TRIPLEX study: use of patient-derived tumor organoids a..:

Divoux, J ; Florent, R ; Jacobs, M...
10.1186/s12885-023-11362-8.  , 2024
Link: https://hdl.handle.net/2..
 
?
11

ORGAVADS: establishment of tumor organoids from head and ne..:

Perréard, M ; Florent, R ; Divoux, J...
10.1186/s12885-023-10692-x.  , 2024
Link: https://hdl.handle.net/2..
 
?
12

The TRIPLEX study: use of patient-derived tumor organoids a..:

Divoux, J ; Florent, R ; Jacobs, M...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12885-023-11362-8.  , 2023
Link: https://hal.univ-lille.f..
 
?
13

Recurrent mutations of the exportin 1 gene (XPO1) and their..:

Jardin, Fabrice ; Pujals, A ; Pelletier, L...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ajh.24451.  , 2016
Link: https://univ-rennes.hal...
 
?
14

Recurrent mutations of the exportin 1 gene (XPO1) and their..:

Jardin, Fabrice ; Pujals, A ; Pelletier, L...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ajh.24451.  , 2016
Link: https://univ-rennes.hal...
 
?
15

Recurrent mutations of the exportin 1 gene (XPO1) and their..:

Jardin, Fabrice ; Pujals, A ; Pelletier, L...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ajh.24451.  , 2016
Link: https://univ-rennes.hal...
 
1-15